Document Detail


Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging.
MedLine Citation:
PMID:  20188503     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: The aim of this study was prospective investigation of silent and clinically apparent cerebral embolic events and neurological impairment after transfemoral aortic valve implantation (TAVI). BACKGROUND: TAVI is a novel therapeutic approach for multimorbid patients with severe aortic stenosis. We investigated peri-interventional cerebral embolism with diffusion-weighted magnetic resonance imaging (DW-MRI) and its relationship to clinical and serologic parameters of brain injury. METHODS: Cerebral DW-MRI was performed before, directly, and 3 months after TAVI with the current third-generation self-expanding CoreValve (Medtronic, Minneapolis, Minnesota) prosthesis. At the timepoints of the serial MRI studies, focal neurological impairment was assessed according to the National Institutes of Health Stroke Scale (NIHSS), and serum concentration of neuron-specific enolase (NSE), a marker of the volume of brain tissue involved in an ischemic event, were determined. RESULTS: Thirty patients were enrolled; 22 completed the imaging protocol. Three patients (10%) had new neurological findings after TAVI, of whom only 1 (3.6%) had a permanent neurological impairment. Of the 22 TAVI patients with complete imaging data, 16 (72.7%) had 75 new cerebral lesions after TAVI presumed to be embolic. The NIHSS and NSE were not correlated with DW-MRI lesions. CONCLUSIONS: The incidence of clinically silent peri-interventional cerebral embolic lesions after TAVI is high. However, in this cohort of 30 patients, the incidence of persistent neurological impairment was low. (Incidence and Severity of Silent and Apparent Cerebral Embolism After Conventional and Minimal-invasive Transfemoral Aortic Valve Replacement; NCT00883285).
Authors:
Alexander Ghanem; Andreas M?ller; Claas P N?hle; Justine Kocurek; Nikos Werner; Christoph Hammerstingl; Hans H Schild; J?rg O Schwab; Fritz Mellert; Rolf Fimmers; Georg Nickenig; Daniel Thomas
Related Documents :
18854443 - Hypercapnia-induced cerebral hyperperfusion: an underrecognized clinical entity.
3891343 - Ultrasound-computerized tomography in neonatal encephalic pathology.
19642403 - Two- and three-dimensional computed tomographic anatomy of the enamel, infundibulae and...
Publication Detail:
Type:  Clinical Trial; Journal Article     Date:  2010-02-24
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  55     ISSN:  1558-3597     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-02     Completed Date:  2010-06-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1427-32     Citation Subset:  AIM; IM    
Copyright Information:
Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Affiliation:
Department of Medicine/Cardiology, University of Bonn, Bonn, Germany. ghanem@uni-bonn.de
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00883285
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Aortic Valve / surgery*
Aortic Valve Stenosis / surgery*
Diffusion Magnetic Resonance Imaging
Female
Femoral Artery / surgery
Heart Valve Prosthesis Implantation / adverse effects*
Humans
Intracranial Embolism / diagnosis*,  etiology*
Male
Pilot Projects
Risk Factors
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Graphic model of birth weight and gestational age in Monastir, Tunisia.
Next Document:  Myocardial Iodine-123 Meta-Iodobenzylguanidine Imaging and Cardiac Events in Heart Failure Results o...